It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved
For medical advice, an in-person or telemedicine consultation is required
Some individuals may experience headache, nausea, pruritus, acneiform eruptions, or dizziness
Through ARSYNL Rx, eligible patients can access MIC B12 injection therapy after completing an online intake and receiving provider review
Each mL contains Cyanocobalamin 1000 mcg, sodium chloride 9 mg and benzyl alcohol 0.015 mL in water for injection
It is commonly used as a solvent for reconstituting lyophilized compounds and preparing multi-dose experimental solutions in controlled research environments